Curesponse to present at BIOMED Israel, 2022

Join Curesponse’s presentation on their precision oncology technology at Israel’s premiere and most established life sciences conference, BIOMED, Israel, 2022.

Curesponse to exhibit at ASCO, 2022

Meet Curesponse at the American Society of Clinical Oncology (ASCO) Annual Meeting, 2022

Curesponse shows applicability with next generation immuno-oncology drugs

Curesponse’s poster presented at the recent ESMO Immuno-Oncology Congress in Geneva showed the cResponse™ platform can be applied for the modeling and evaluation of immune modulating drugs in cancer tissue.The cResponse™ assay maintains the high viability of human cancer, uniquely preserving the 3D architecture together with its microenvironment, including immune cells for sufficient time to […]